BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2960742)

  • 1. Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells.
    Edberg JC; Wright E; Taylor RP
    J Immunol; 1987 Dec; 139(11):3739-47. PubMed ID: 2960742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kinetics of [3H]-dsDNA/anti-DNA immune complex formation, binding by red blood cells, and release into serum: effect of DNA molecular weight and conditions of antibody excess.
    Horgan C; Burge J; Crawford L; Taylor RP
    J Immunol; 1984 Oct; 133(4):2079-84. PubMed ID: 6332147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells.
    Emlen W; Burdick G; Carl V; Lachmann PJ
    J Immunol; 1989 Jun; 142(12):4366-71. PubMed ID: 2524529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
    Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
    Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complement-mediated binding of soluble antibody/dsDNA immune complexes to human neutrophils.
    Taylor RP; Burge J; Horgan C; Shasby DM
    J Immunol; 1983 Jun; 130(6):2656-62. PubMed ID: 6854016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analyses of C3b capture and immune adherence of IgM antibody/dsDNA immune complexes.
    Taylor RP; Wright EL; Pocanic F
    J Immunol; 1989 Dec; 143(11):3626-31. PubMed ID: 2584711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The binding of immune complexes to human red cells: complement requirements and fate of the RBC-bound IC after interaction with human phagocytic cells.
    Sherwood TA; Virella G
    Clin Exp Immunol; 1986 Apr; 64(1):195-204. PubMed ID: 3731526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A kinetic study of erythrocyte-DNA/anti-DNA immune complex association and dissociation reactions in systemic lupus erythematosus.
    Meryhew NL; Westling PR; Eerdmans ME; Janecek EJ; Runquist OA
    Biochim Biophys Acta; 1989 Jun; 991(3):470-6. PubMed ID: 2786431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement-opsonized IgG antibody/dsDNA immune complexes bind to CR1 clusters on isolated human erythrocytes.
    Taylor RP; Pocanic F; Reist C; Wright EL
    Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 1):143-60. PubMed ID: 1833104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
    Schifferli JA; Ng YC; Paccaud JP; Walport MJ
    Clin Exp Immunol; 1989 Mar; 75(3):329-35. PubMed ID: 2522842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.
    Ng YC; Schifferli JA; Walport MJ
    Clin Exp Immunol; 1988 Mar; 71(3):481-5. PubMed ID: 2968204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
    Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
    J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in the clustering of complement receptor type 1 (CR1) on polymorphonuclear leukocytes and erythrocytes: effect on immune adherence.
    Paccaud JP; Carpentier JL; Schifferli JA
    Eur J Immunol; 1990 Feb; 20(2):283-9. PubMed ID: 2138082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lysine-binding protein in SLE sera inhibits the binding of immune complexes to normal erythrocyte CR1 (complement receptor type 1).
    Ng YC; Peters DK; Cederholm-Williams SA; Walport MJ
    Clin Exp Immunol; 1987 Jul; 69(1):89-97. PubMed ID: 3115654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil Fc gamma and complement receptors involved in binding soluble IgG immune complexes and in specific granule release induced by soluble IgG immune complexes.
    Voice JK; Lachmann PJ
    Eur J Immunol; 1997 Oct; 27(10):2514-23. PubMed ID: 9368604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro studies of the binding of antibody/dsDNA immune complexes to rabbit and guinea pig platelets.
    Taylor RP; Kujala G; Wilson K; Wright E; Harbin A
    J Immunol; 1985 Apr; 134(4):2550-8. PubMed ID: 3919101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].
    Pascual M; Schifferli JA
    Schweiz Med Wochenschr; 1993 Jan; 123(3):39-43. PubMed ID: 8426946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competition for immune complexes by red cells in human blood.
    Medof ME; Oger JJ
    J Clin Lab Immunol; 1982 Jan; 7(1):7-13. PubMed ID: 7069779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of non-human primate erythrocyte immune adherence receptors: implications for the uptake of immune complexes by the cells of the mononuclear phagocytic system.
    Edberg JC; Kimberly RP; Taylor RP
    Eur J Immunol; 1992 Jun; 22(6):1333-9. PubMed ID: 1376254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of interaction of immune complexes with complement receptors on human blood cells: modification of complexes during interaction with red cells.
    Medof ME; Prince GM; Oger JJ
    Clin Exp Immunol; 1982 Jun; 48(3):715-25. PubMed ID: 7116690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.